CLB Leading the Way to Affordable Therapeutics
Q & A with Dr. John Zhang, COO of CL Biologics Question: What is CLB’s organizational goal? At CL Biologics (CLB), our goal is to provide affordable medicines to the…
read moreQ & A with Dr. John Zhang, COO of CL Biologics Question: What is CLB’s organizational goal? At CL Biologics (CLB), our goal is to provide affordable medicines to the…
read moreBiomanufacturing 4.0 is a technology that is revolutionizing the way pharmaceuticals are produced. This new technology utilizes oversized stainless steel bioreactors for the efficient production of antibody drugs. These bioreactors…
read moreSeptember 22, 2022, Shenzhen – CL Biologics (CLB) announces today at the CLB Watson Center for Life Sciences and Technology the launch of its digital Quality Management Suites (eQMS), integrating…
read moreIn recent years, the application of the Industry 4.0 framework has become increasingly popular in biologics manufacturing. By utilizing the latest digital technologies, biologic manufacturers can create more efficient, cost-effective,…
read more